Introduction     Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease Karen L. Bell, M.D.     Treatment Strategies for Dementia and Mild Cognitive Impairment Mary Sano, Ph.D.     Treatment of Depression, Agitation, and Psychosis in Dementia Davangere P. Devanand, M.D.     Recognition of Vascular Dementia, Dementia with Lewy Bodies, and Frontotemporal Dementia Lawrence S. Honig, M.D., Ph.D.     Neuropsychology of Mild Cognitive Impairment, Alzheimer's Disease, Dementia with Lewy Bodies, and Frontotemporal Dementia Penne Sims, Ph.D.     Neuroimaging in Dementia Scott A. Small, M.D.     Genetics of Neurodegenerative Disease: Alzheimer's Disease, Frontotemporal Dementia Jennifer Williamson-Catania, M.S.     Legal and Ethical Issues for Patients with Dementia Daniel G. Fish, Esq.     Posttest         Accreditation     Reference List     Acknowledgements		Outline Home Introduction Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease, Karen L. Bell, M.D. Defining Alzheimer's Disease Evaluating Patients Pre-Dementia Impairment Mild Cognitive Impairment Treatment Strategies for Dementia and Mild Cognitive Impairment, Mary Sano, Ph.D. Cholinergic Treatment Administering Drugs Targeting Other Mechanisms Managing and Treating MCI Models for AD Prevention AD Prevention Agents Treatment of Depression, Agitation, and Psychosis in Dementia, Davangere P. Devanand, M.D. Common Symptoms Data on Symptoms Data on Treatment Choosing a Drug Assessing Depression Treatment of Depression Recognition of Vascular Dementia, Dementia with Lewy Bodies, and Frontotemporal Dementia, Lawrence S. Honig, M.D., Ph.D. Categorization of Dementias Prevalence of Non-Alzheimer's Dementias The Spectrum of Lewy-Body Disease Frontotemporal Dementia Other Frontotemporal Dementia Vascular Dementia Other Non-Alzheimer's Dementias Neuropsychology of Mild Cognitive Impairment, Alzheimer's Disease, Dementia with Lewy Bodies, and Frontotemporal Dementia, Penne Sims, Ph.D. What Is Assessed Neuropsychology in Differential Diagnosis Screening Measures Protocol of a Declining Patient Protocol for Lewy Bodies Protocol for FTLD Benefits of Testing Neuroimaging in Dementia, Scott A. Small, M.D. Neurobiological Correlates Metabolism in Imaging Imaging Modalities Diagnostic Specificity Early Detection Genetics of Neurodegenerative Disease: Alzheimer's Disease, Frontotemporal Dementia, Jennifer Williamson-Catania, M.S. Family Patterns in Alzheimer's Disease Genetics of Early-Onset AD Genetics of Late-Onset AD Genetic Testing for AD Genetic Testing for FTD Why Offer Testing? Legal and Ethical Issues for Patients with Dementia, Daniel G. Fish, Esq. Avoiding the Courthouse Agents and Trustees Health-Care Proxy and Living Will Cost of Long-Term Care Posttest Accreditation Reference List Acknowledgements